Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.71
-0.32 (-3.99%)
At close: Jun 13, 2025, 4:00 PM
7.98
+0.27 (3.50%)
After-hours: Jun 13, 2025, 7:25 PM EDT
Aligos Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Aligos Therapeutics stock has a target of 70, which predicts a 807.91% increase from the current stock price of 7.71.
Price Target: $70.00 (+807.91%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 31, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Aligos Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +807.91% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $70 | Strong Buy | Maintains | $75 → $70 | +807.91% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +872.76% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +872.76% | Oct 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +872.76% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
2.89M
from 3.95M
Decreased by -26.67%
Revenue Next Year
2.89M
from 2.89M
Decreased by -0.10%
EPS This Year
-9.90
from -20.94
EPS Next Year
-10.66
from -9.90
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.4M | 4.7M | 5.1M | ||
| Avg | 2.9M | 2.9M | 2.5M | ||
| Low | 303,800 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.8% | 63.3% | 78.0% | ||
| Avg | -26.7% | -0.1% | -13.5% | ||
| Low | -92.3% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.11 | -10.42 | -22.03 | ||
| Avg | -9.90 | -10.66 | -21.40 | ||
| Low | -10.53 | -10.76 | -20.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.